SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001485003-17-000018
Filing Date
2017-03-24
Accepted
2017-03-24 17:27:25
Documents
99
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ebio-123116x10k.htm 10-K 2728818
2 EXHIBIT 21.1 ebio-123116x211.htm EX-21.1 4898
3 EXHIBIT 23.1 ebio-123116x231.htm EX-23.1 6104
4 EXHIBIT 31.1 ebio-123116x311.htm EX-31.1 12303
5 EXHIBIT 31.2 ebio-123116x312.htm EX-31.2 12055
6 EXHIBIT 32.1 ebio-123116x321.htm EX-32.1 6753
13 ebiopipelinecharta01.jpg GRAPHIC 91070
14 figure5.jpg GRAPHIC 78080
15 proxinjectedtumors.jpg GRAPHIC 128418
16 proxuninjectedtumors.jpg GRAPHIC 107938
17 scchn.jpg GRAPHIC 168626
18 treatmentarma.jpg GRAPHIC 63565
19 treatmentarmb.jpg GRAPHIC 78742
20 vb6845d.jpg GRAPHIC 47429
21 vb6845preclinicaldata.jpg GRAPHIC 33618
  Complete submission text file 0001485003-17-000018.txt   11055632

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ebio-20161231.xml EX-101.INS 1655239
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebio-20161231.xsd EX-101.SCH 73430
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ebio-20161231_cal.xml EX-101.CAL 97606
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebio-20161231_def.xml EX-101.DEF 406672
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebio-20161231_lab.xml EX-101.LAB 955800
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebio-20161231_pre.xml EX-101.PRE 605330
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36296 | Film No.: 17713649
SIC: 2834 Pharmaceutical Preparations